Literature DB >> 8972421

Magnetic resonance brain imaging lacks sensitivity for AIDS associated cytomegalovirus encephalitis.

D B Clifford1, J R Arribas, G A Storch, W Tourtellote, F J Wippold.   

Abstract

Six patients are presented who died with active cytomegalovirus (CMV) encephalitis in whom brain MR scans within 25 days of death failed to reveal distinctive findings suggesting the diagnosis of CMV encephalitis. While MR scanning is crucial to evulation of AIDS patients developing neurologic complications, it is not sensitive to the presence of CMV encephalitis even when it is quite severe. The diagnosis of CMV encephalitis during life rests on characteristic clinical findings supported by a typical laboratory measures including the presence of CMV DNA in cerebrospinal fluid as detected by polymerase chain reaction.

Entities:  

Mesh:

Year:  1996        PMID: 8972421     DOI: 10.3109/13550289609146905

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  4 in total

Review 1.  PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section.

Authors:  Joseph R Berger; Allen J Aksamit; David B Clifford; Larry Davis; Igor J Koralnik; James J Sejvar; Russell Bartt; Eugene O Major; Avindra Nath
Journal:  Neurology       Date:  2013-04-09       Impact factor: 9.910

Review 2.  CNS manifestations of cytomegalovirus infections: diagnosis and treatment.

Authors:  Matthias Maschke; Oliver Kastrup; Hans-Christoph Diener
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 3.  Central nervous system infections in individuals with HIV-1 infection.

Authors:  Arunima Mamidi; Joseph A DeSimone; Roger J Pomerantz
Journal:  J Neurovirol       Date:  2002-06       Impact factor: 2.643

4.  Mononeuritis multiplex: an uncommon neurological manifestation of cytomegalovirus reactivation in an HIV-infected patient.

Authors:  Pedro Palma; Andreia Costa; Raquel Duro; Nélia Neves; Cândida Abreu; António Sarmento
Journal:  BMC Infect Dis       Date:  2018-11-12       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.